ANR — Anatara Lifesciences Balance Sheet
0.000.00%
- AU$1.17m
- AU$0.07m
Annual balance sheet for Anatara Lifesciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.68 | 3.43 | 1.17 | 0.401 | 0.982 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.63 | 0.773 | 0.509 | 1 | 0.671 |
Total Other Current Assets | |||||
Total Current Assets | 3.34 | 4.24 | 1.7 | 1.42 | 1.67 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.007 | 0.085 | 0.067 | 0.003 | 0.001 |
Net Intangible Assets | |||||
Total Assets | 3.34 | 4.33 | 1.77 | 1.42 | 1.67 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.464 | 0.403 | 0.358 | 0.494 | 0.304 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.487 | 0.497 | 0.403 | 0.495 | 0.307 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2.86 | 3.83 | 1.36 | 0.925 | 1.36 |
Total Liabilities & Shareholders' Equity | 3.34 | 4.33 | 1.77 | 1.42 | 1.67 |
Total Common Shares Outstanding |